Haloperidol
- Product NDC
- 72888-173
- 11-digit product format
- 728880173
- Labeler code
- 72888
- Product ID
- 72888-173_45c7bbb4-7235-89a8-e063-6394a90a7ea0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Haloperidol
- Dosage form
- SOLUTION, CONCENTRATE
- Route
- ORAL
- Labeler
- Advagen Pharma Ltd
- Application
- ANDA218371
- Marketing category
- ANDA
- Marketing start
- 2024-01-31
- Substance
- HALOPERIDOL
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Typical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Haloperidol
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| HALOPERIDOL | 2 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | J6292F8L3D |
| Rxcui | 141935 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72888-173-47 | Haloperidol | 15 mL in 1 BOTTLE | SOLUTION, CONCENTRATE | 15 | | 3 |
| 72888-173-48 | Haloperidol | 120 mL in 1 BOTTLE | SOLUTION, CONCENTRATE | 120 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72888-173 | HALOPERIDOL SOLUTION, CONCENTRATE [ADVAGEN PHARMA LTD] | 1 | Current NDC, 2 package rows | 20240227_8bfdc739-51b4-4914-9a60-923e83762307.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72888-173-47 | 72888017347 | 15 mL in 1 BOTTLE (72888-173-47) | 15 ml | 2024-01-31 | No | No | Historical |
| 72888-173-48 | 72888017348 | 120 mL in 1 BOTTLE (72888-173-48) | 120 ml | 2024-01-31 | No | No | Historical |